Global Blood Therapeutics Inc (GBT)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

181 OYSTER POINT BLVD SOUTH SAN FRANCISCO, CA 94080

Global Blood Therapeutics (GBT) is a biopharmaceutical company dedicated to the discovery, development, and delivery of life-changing treatments that provide hope to underserved patient communities. Founded in 2011, GBT is delivering on its goal to transform the treatment and care of sickle cell disease (SCD), a lifelong, devastating inherited blood disorder. The company has introduced Oxbryta® (voxelotor) tablets, the first FDA-approved treatment that directly inhibits sickle hemoglobin polymerization, the root cause of red blood cell sickling in SCD. GBT is also advancing its pipeline program in SCD with inclacumab, a P-selectin inhibitor in development to address pain crises associated with the disease, and GBT021601 (GBT601), the company's next generation hemoglobin S polymerization inhibitor. In addition, GBT's drug discovery teams are working on new targets to develop the next wave of treatments for SCD.

Data as of 2021-09-19 13:00:06 -0400
Market Cap1.749 Billion Shares Outstanding62.412 Million Avg 30-day Volume1.116 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE9.52 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.85588 52-week High/Low64.49 / 25.48 Next Earnings Date2021-11-03 Price to Cash FLow (P/CF) -31.3363
Data provided by IEX Cloud
View SEC Filings from GBT instead.

View recent insider trading info

Funds Holding GBT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GBT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

4.8 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

148.8 Thousand total shares from 15 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MORRISON SCOTT W

  • Director
3,037 2021-09-09 2

LOVE TED W PRESIDENT AND CEO

  • Officer
  • Director
964,786 2021-09-01 5

SUVARI TRICIA BORGA CHIEF LEGAL OFFICER

  • Officer
46,808 2021-09-01 5

FARROW JEFFREY S CHIEF FINANCIAL OFFICER

  • Officer
40,800 2021-09-01 5

CHOI JUNG SEE REMARKS

  • Officer
228,227 2021-09-01 5

JOHNSON DAVID LEE CHIEF COMMERCIAL OFFICER

  • Officer
56,207 2021-09-01 7

KREHLIK CARRIE CHIEF HUMAN RESOURCES OFFICER

  • Officer
124,240 2021-09-01 2

PATRICK DEVAL L

  • Director
14,637 2021-06-17 1

YARNO WENDY L

  • Director
17,037 2021-06-17 1

PERRY MARK L

  • Director
43,465 2021-06-17 1

PIERCE GLENN

  • Director
32,037 2021-06-17 1

PIZZO PHILIP A.

  • Director
23,809 2021-06-17 1

SVORONOS DAWN

  • Director
18,177 2021-06-17 1

BROWN WILLIE L. JR.

  • Director
48,465 2021-06-17 1

THOMPSON ALEXIS A.

  • Director
2,320 2021-06-17 3

SMITH-WHITLEY KIM SEE REMARKS

  • Officer
65,960 2021-06-01 3

FINK ERIC CHIEF HUMAN RESOURCES OFFICER

  • Officer
5,161 2021-05-10 4

CATHERS BRIAN EDWIN CHIEF SCIENTIFIC OFFICER

  • Officer
75,820 2021-03-01 2

CALHOUN LESLEY ANN SEE REMARKS

  • Officer
154 2020-05-26 0

LEHRER-GRAIWER JOSHUA CHIEF MEDICAL OFFICER

  • Officer
2,595 2020-03-05 0

HOMCY CHARLES J

  • Director
0 2018-06-20 0

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2018-03-08 0

SHAM HING SEE REMARKS

  • Officer
98,215 2018-03-07 0

RADOVICH PETER SEE REMARKS

  • Officer
8,833 2018-02-14 0

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

LEVIN MARK J

TEPPER ROBERT I

STARR KEVIN P

  • 10% Owner
No longer subject to file 2017-06-14 0

TEPPER ROBERT I

  • 10% Owner
4,990,677 2017-04-06 0

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

TEPPER ROBERT I

STARR KEVIN P

  • 10% Owner
420,253 2017-03-02 0

STARR KEVIN P

  • 10% Owner
8,843,448 2016-12-16 0

RAMOS ELEANOR CHIEF MEDICAL OFFICER

  • Officer
0 2016-09-29 0

BONNEY MICHAEL W

  • Director
0 2016-06-16 0

SCHEMBRI JOHN SEE REMARKS

  • Officer
0 2016-03-10 0

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
12,475,191 2015-08-17 0

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
2,285,713 2015-08-17 0

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
571,428 2015-08-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MORRISON SCOTT W - Director

2021-09-10 20:00:17 -0400 2021-09-09 S 4,800 $30.21 d 3,037 direct -3.6996 -0.7326 2.674 5 -4.8718 3

JOHNSON DAVID LEE - Officer CHIEF COMMERCIAL OFFICER

2021-09-03 20:01:07 -0400 2021-09-01 M 2,762 a 37,939 direct 0.7049 -11.7489 1.1078 3 -11.7489 6

CHOI JUNG - Officer SEE REMARKS

2021-09-03 20:01:09 -0400 2021-09-01 F 1,370 $29.85 d 183,887 direct 0.7049 -11.7489 1.1078 3 -11.7489 6

KREHLIK CARRIE - Officer CHIEF HUMAN RESOURCES OFFICER

2021-09-02 20:00:29 -0400 2021-09-01 A 49,600 a 49,600 direct

LOVE TED W - Director - Officer PRESIDENT AND CEO

2021-09-03 20:00:36 -0400 2021-09-01 F 4,683 $29.85 d 794,174 direct 0.7049 -11.7489 1.1078 3 -11.7489 6

FARROW JEFFREY S - Officer CHIEF FINANCIAL OFFICER

2021-09-03 20:00:44 -0400 2021-09-01 F 1,370 $29.85 d 21,460 direct 0.7049 -11.7489 1.1078 3 -11.7489 6

SUVARI TRICIA BORGA - Officer CHIEF LEGAL OFFICER

2021-09-03 20:00:52 -0400 2021-09-01 F 1,047 $29.85 d 27,468 direct 0.7049 -11.7489 1.1078 3 -11.7489 6

JOHNSON DAVID LEE - Officer CHIEF COMMERCIAL OFFICER

2021-09-03 20:01:07 -0400 2021-09-01 M 2,762 d 19,340 direct

CHOI JUNG - Officer SEE REMARKS

2021-09-03 20:01:09 -0400 2021-09-01 M 2,762 a 185,257 direct 0.7049 -11.7489 1.1078 3 -11.7489 6

KREHLIK CARRIE - Officer CHIEF HUMAN RESOURCES OFFICER

2021-09-02 20:00:29 -0400 2021-09-01 A 42,400 a 42,400 direct

LOVE TED W - Director - Officer PRESIDENT AND CEO

2021-09-03 20:00:36 -0400 2021-09-01 M 9,444 a 798,857 direct 0.7049 -11.7489 1.1078 3 -11.7489 6

FARROW JEFFREY S - Officer CHIEF FINANCIAL OFFICER

2021-09-03 20:00:44 -0400 2021-09-01 M 2,762 a 22,830 direct 0.7049 -11.7489 1.1078 3 -11.7489 6

SUVARI TRICIA BORGA - Officer CHIEF LEGAL OFFICER

2021-09-03 20:00:52 -0400 2021-09-01 M 2,762 a 28,515 direct 0.7049 -11.7489 1.1078 3 -11.7489 6

JOHNSON DAVID LEE - Officer CHIEF COMMERCIAL OFFICER

2021-09-03 20:01:07 -0400 2021-09-01 F 1,072 $29.85 d 36,867 direct 0.7049 -11.7489 1.1078 3 -11.7489 6

CHOI JUNG - Officer SEE REMARKS

2021-09-03 20:01:09 -0400 2021-09-01 M 2,762 d 19,340 direct

KREHLIK CARRIE - Officer CHIEF HUMAN RESOURCES OFFICER

2021-09-02 20:00:29 -0400 2021-09-01 A 32,240 a 32,240 direct

LOVE TED W - Director - Officer PRESIDENT AND CEO

2021-09-03 20:00:36 -0400 2021-09-01 M 9,444 d 66,112 direct

FARROW JEFFREY S - Officer CHIEF FINANCIAL OFFICER

2021-09-03 20:00:44 -0400 2021-09-01 M 2,762 d 19,340 direct

SUVARI TRICIA BORGA - Officer CHIEF LEGAL OFFICER

2021-09-03 20:00:52 -0400 2021-09-01 M 2,762 d 19,340 direct

JOHNSON DAVID LEE - Officer CHIEF COMMERCIAL OFFICER

2021-09-03 20:01:07 -0400 2021-08-31 A 480 $24.39 a 35,177 direct 0.7049 -11.7489 1.1078 3 -11.7489 6

CHOI JUNG - Officer SEE REMARKS

2021-09-03 20:01:09 -0400 2021-08-31 A 128 $24.39 a 182,495 direct 0.7049 -11.7489 1.1078 3 -11.7489 6

SUVARI TRICIA BORGA - Officer CHIEF LEGAL OFFICER

2021-09-03 20:00:52 -0400 2021-08-31 A 43 $24.39 a 25,753 direct 0.7049 -11.7489 1.1078 3 -11.7489 6

JOHNSON DAVID LEE - Officer CHIEF COMMERCIAL OFFICER

2021-09-24 19:00:19 -0400 2021-08-01 M 3,645 d 18,225 direct

SUVARI TRICIA BORGA - Officer CHIEF LEGAL OFFICER

2021-08-03 18:07:37 -0400 2021-08-01 M 9,395 a 28,960 direct 3.5028 -7.0366 -18.3199 4.1228 3 -19.8698 12

JOHNSON DAVID LEE - Officer CHIEF COMMERCIAL OFFICER

2021-09-24 19:00:19 -0400 2021-08-01 M 6,770 a 37,039 direct

FARROW JEFFREY S - Officer CHIEF FINANCIAL OFFICER

2021-09-24 19:00:23 -0400 2021-08-01 M 2,875 d 2,875 direct

CHOI JUNG - Officer SEE REMARKS

2021-09-24 19:00:24 -0400 2021-08-01 M 3,020 d 15,100 direct

LOVE TED W - Director - Officer PRESIDENT AND CEO

2021-08-03 19:07:22 -0400 2021-08-01 M 8,955 d 44,775 direct

CHOI JUNG - Officer SEE REMARKS

2021-09-24 19:00:24 -0400 2021-08-01 F 3,743 $27.33 d 182,367 direct

LOVE TED W - Director - Officer PRESIDENT AND CEO

2021-08-03 19:07:22 -0400 2021-08-01 F 14,853 $27.33 d 789,413 direct 3.5028 -7.0366 -18.3199 4.1228 3 -19.8698 12

SUVARI TRICIA BORGA - Officer CHIEF LEGAL OFFICER

2021-09-24 19:00:11 -0400 2021-08-01 M 3,125 d 9,375 direct

CHOI JUNG - Officer SEE REMARKS

2021-08-03 18:29:16 -0400 2021-08-01 M 3,125 d 9,375 direct

SUVARI TRICIA BORGA - Officer CHIEF LEGAL OFFICER

2021-09-24 19:00:11 -0400 2021-08-01 M 9,395 a 28,960 direct

CHOI JUNG - Officer SEE REMARKS

2021-08-03 18:29:16 -0400 2021-08-01 M 9,020 a 186,110 direct 3.5028 -7.0366 -18.3199 4.1228 3 -19.8698 12

FARROW JEFFREY S - Officer CHIEF FINANCIAL OFFICER

2021-08-03 18:19:58 -0400 2021-08-01 M 2,875 d 2,875 direct

JOHNSON DAVID LEE - Officer CHIEF COMMERCIAL OFFICER

2021-08-03 18:09:25 -0400 2021-08-01 M 3,645 d 18,225 direct

LOVE TED W - Director - Officer PRESIDENT AND CEO

2021-09-24 19:00:15 -0400 2021-08-01 M 8,955 d 44,775 direct

JOHNSON DAVID LEE - Officer CHIEF COMMERCIAL OFFICER

2021-08-03 18:09:25 -0400 2021-08-01 M 6,770 a 37,039 direct 3.5028 -7.0366 -18.3199 4.1228 3 -19.8698 12

LOVE TED W - Director - Officer PRESIDENT AND CEO

2021-09-24 19:00:15 -0400 2021-08-01 F 14,853 $27.33 d 789,413 direct

SUVARI TRICIA BORGA - Officer CHIEF LEGAL OFFICER

2021-08-03 18:07:37 -0400 2021-08-01 M 3,250 d 3,250 direct

JOHNSON DAVID LEE - Officer CHIEF COMMERCIAL OFFICER

2021-09-24 19:00:19 -0400 2021-08-01 M 3,125 d 9,375 direct

FARROW JEFFREY S - Officer CHIEF FINANCIAL OFFICER

2021-09-24 19:00:23 -0400 2021-08-01 M 3,020 d 15,100 direct

FARROW JEFFREY S - Officer CHIEF FINANCIAL OFFICER

2021-09-24 19:00:23 -0400 2021-08-01 F 4,354 $27.33 d 20,068 direct

CHOI JUNG - Officer SEE REMARKS

2021-09-24 19:00:24 -0400 2021-08-01 M 3,125 d 9,375 direct

LOVE TED W - Director - Officer PRESIDENT AND CEO

2021-08-03 19:07:22 -0400 2021-08-01 M 11,250 d 33,750 direct

CHOI JUNG - Officer SEE REMARKS

2021-09-24 19:00:24 -0400 2021-08-01 M 9,020 a 186,110 direct

LOVE TED W - Director - Officer PRESIDENT AND CEO

2021-08-03 19:07:22 -0400 2021-08-01 M 29,955 a 804,266 direct 3.5028 -7.0366 -18.3199 4.1228 3 -19.8698 12

SUVARI TRICIA BORGA - Officer CHIEF LEGAL OFFICER

2021-09-24 19:00:11 -0400 2021-08-01 M 3,250 d 3,250 direct

CHOI JUNG - Officer SEE REMARKS

2021-08-03 18:29:16 -0400 2021-08-01 M 2,875 d 2,875 direct

FARROW JEFFREY S - Officer CHIEF FINANCIAL OFFICER

2021-08-03 18:19:58 -0400 2021-08-01 M 3,020 d 15,100 direct

FARROW JEFFREY S - Officer CHIEF FINANCIAL OFFICER

2021-08-03 18:19:58 -0400 2021-08-01 F 4,354 $27.33 d 20,068 direct 3.5028 -7.0366 -18.3199 4.1228 3 -19.8698 12

JOHNSON DAVID LEE - Officer CHIEF COMMERCIAL OFFICER

2021-08-03 18:09:25 -0400 2021-08-01 M 3,125 d 9,375 direct

LOVE TED W - Director - Officer PRESIDENT AND CEO

2021-09-24 19:00:15 -0400 2021-08-01 M 11,250 d 33,750 direct

SUVARI TRICIA BORGA - Officer CHIEF LEGAL OFFICER

2021-08-03 18:07:37 -0400 2021-08-01 M 3,020 d 15,100 direct

LOVE TED W - Director - Officer PRESIDENT AND CEO

2021-09-24 19:00:15 -0400 2021-08-01 M 29,955 a 804,266 direct

SUVARI TRICIA BORGA - Officer CHIEF LEGAL OFFICER

2021-08-03 18:07:37 -0400 2021-08-01 F 3,250 $27.33 d 25,710 direct 3.5028 -7.0366 -18.3199 4.1228 3 -19.8698 12

JOHNSON DAVID LEE - Officer CHIEF COMMERCIAL OFFICER

2021-09-24 19:00:19 -0400 2021-08-01 F 2,342 $27.33 d 34,697 direct

FARROW JEFFREY S - Officer CHIEF FINANCIAL OFFICER

2021-09-24 19:00:23 -0400 2021-08-01 M 3,125 d 9,375 direct

FARROW JEFFREY S - Officer CHIEF FINANCIAL OFFICER

2021-09-24 19:00:23 -0400 2021-08-01 M 9,020 a 24,422 direct

CHOI JUNG - Officer SEE REMARKS

2021-09-24 19:00:24 -0400 2021-08-01 M 2,875 d 2,875 direct

LOVE TED W - Director - Officer PRESIDENT AND CEO

2021-08-03 19:07:22 -0400 2021-08-01 M 9,750 d 9,750 direct

SUVARI TRICIA BORGA - Officer CHIEF LEGAL OFFICER

2021-09-24 19:00:11 -0400 2021-08-01 M 3,020 d 15,100 direct

CHOI JUNG - Officer SEE REMARKS

2021-08-03 18:29:16 -0400 2021-08-01 M 3,020 d 15,100 direct

SUVARI TRICIA BORGA - Officer CHIEF LEGAL OFFICER

2021-09-24 19:00:11 -0400 2021-08-01 F 3,250 $27.33 d 25,710 direct

CHOI JUNG - Officer SEE REMARKS

2021-08-03 18:29:16 -0400 2021-08-01 F 3,743 $27.33 d 182,367 direct 3.5028 -7.0366 -18.3199 4.1228 3 -19.8698 12

FARROW JEFFREY S - Officer CHIEF FINANCIAL OFFICER

2021-08-03 18:19:58 -0400 2021-08-01 M 3,125 d 9,375 direct

FARROW JEFFREY S - Officer CHIEF FINANCIAL OFFICER

2021-08-03 18:19:58 -0400 2021-08-01 M 9,020 a 24,422 direct 3.5028 -7.0366 -18.3199 4.1228 3 -19.8698 12

JOHNSON DAVID LEE - Officer CHIEF COMMERCIAL OFFICER

2021-08-03 18:09:25 -0400 2021-08-01 F 2,342 $27.33 d 34,697 direct 3.5028 -7.0366 -18.3199 4.1228 3 -19.8698 12

LOVE TED W - Director - Officer PRESIDENT AND CEO

2021-09-24 19:00:15 -0400 2021-08-01 M 9,750 d 9,750 direct

SUVARI TRICIA BORGA - Officer CHIEF LEGAL OFFICER

2021-08-03 18:07:37 -0400 2021-08-01 M 3,125 d 9,375 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 22:15:03 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 21:45:03 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 21:15:03 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 20:45:03 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 20:15:03 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 19:45:03 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 19:15:03 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 18:45:03 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 18:15:03 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 17:45:03 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 17:15:03 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 16:45:03 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 16:15:03 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 15:45:03 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 15:15:04 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 14:45:02 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 14:15:02 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 13:45:02 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 13:15:03 UTC -0.18 0.25 1000000
GLOBAL BLOOD THERAPEUTICS IN GBT 2021-09-24 12:45:03 UTC -0.18 0.25 1000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund GBT -1104.0 shares, $-87756.96 2019-12-31 N-PORT
Trust for Professional Managers- Convergence Market Neutral Fund GBT -1028.0 shares, $-64537.84 2020-08-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund GBT -18.0 shares, $-992.52 2020-09-30 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund GBT -1.0 shares, $-51.09 2020-03-31 N-PORT
JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund GBT -9326.0 shares, $-380034.5 2021-03-31 N-PORT
Trust for Professional Managers- Convergence Long/Short Equity Fund GBT -858.0 shares, $-32972.94 2021-05-31 N-PORT
RBB Fund, Inc.- Boston Partners Long/Short Research Fund GBT -14579.0 shares, $-560270.97 2021-05-31 N-PORT
TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund GBT -12418.0 shares, $-434878.36 2021-06-30 N-PORT
Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio GBT -22800.0 shares, $-798456.0 2021-06-30 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund GBT -588.0 shares, $-20591.76 2021-06-30 N-PORT
Prudential Investment Portfolios 12- PGIM QMA Large-Cap Core Equity Plus Fund GBT -1400.0 shares, $-49028.0 2021-06-30 N-PORT
Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund GBT -4500.0 shares, $-157590.0 2021-06-30 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund GBT -1000.0 shares, $-35020.0 2021-06-30 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund GBT -8047.0 shares, $-281805.94 2021-06-30 N-PORT
AQR Funds- AQR Multi-Asset Fund GBT -1980.0 shares, $-69339.6 2021-06-30 N-PORT
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund GBT -1893.0 shares, $-51735.69 2021-07-31 N-PORT

Elevate your investments